These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21487042)

  • 21. Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus.
    Flores-Martínez YA; Le-Trilling VTK; Trilling M
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.
    Soucy TA; Smith PG; Milhollen MA; Berger AJ; Gavin JM; Adhikari S; Brownell JE; Burke KE; Cardin DP; Critchley S; Cullis CA; Doucette A; Garnsey JJ; Gaulin JL; Gershman RE; Lublinsky AR; McDonald A; Mizutani H; Narayanan U; Olhava EJ; Peluso S; Rezaei M; Sintchak MD; Talreja T; Thomas MP; Traore T; Vyskocil S; Weatherhead GS; Yu J; Zhang J; Dick LR; Claiborne CF; Rolfe M; Bolen JB; Langston SP
    Nature; 2009 Apr; 458(7239):732-6. PubMed ID: 19360080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human geminin promotes pre-RC formation and DNA replication by stabilizing CDT1 in mitosis.
    Ballabeni A; Melixetian M; Zamponi R; Masiero L; Marinoni F; Helin K
    EMBO J; 2004 Aug; 23(15):3122-32. PubMed ID: 15257290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.
    Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L
    Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MLN4924 therapy as a novel approach in cancer treatment modalities.
    Oladghaffari M; Islamian JP; Baradaran B; Monfared AS
    J Chemother; 2016 Apr; 28(2):74-82. PubMed ID: 26292710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents.
    Paiva C; Godbersen JC; Berger A; Brown JR; Danilov AV
    Cell Death Dis; 2015 Jul; 6(7):e1807. PubMed ID: 26158513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia.
    Swords RT; Kelly KR; Smith PG; Garnsey JJ; Mahalingam D; Medina E; Oberheu K; Padmanabhan S; O'Dwyer M; Nawrocki ST; Giles FJ; Carew JS
    Blood; 2010 May; 115(18):3796-800. PubMed ID: 20203261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiosensitization of Human Colorectal Cancer Cells by MLN4924: An Inhibitor of NEDD8-Activating Enzyme.
    Wan J; Zhu J; Li G; Zhang Z
    Technol Cancer Res Treat; 2016 Aug; 15(4):527-34. PubMed ID: 26082455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of a neddylation blockade on HTLV-1-infected T cells
    Ishikawa C; Mori N
    Leuk Lymphoma; 2024 Jul; 65(7):978-988. PubMed ID: 38489672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924).
    Wong KM; Micel LN; Selby HM; Tan AC; Pitts TM; Bagby SM; Spreafico A; Klauck PJ; Blakemore SJ; Smith PF; McDonald A; Berger A; Tentler JJ; Eckhardt SG
    Invest New Drugs; 2017 Feb; 35(1):11-25. PubMed ID: 27783255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases.
    Gastaldello S; Hildebrand S; Faridani O; Callegari S; Palmkvist M; Di Guglielmo C; Masucci MG
    Nat Cell Biol; 2010 Apr; 12(4):351-61. PubMed ID: 20190741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and application of NEDD8 E1 inhibitors.
    Bruzzese FJ; Milhollen MA; Gavin JM; Josephine HR; Brownell JE
    Methods Mol Biol; 2012; 832():577-88. PubMed ID: 22350913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nedd8 on cullin: building an expressway to protein destruction.
    Pan ZQ; Kentsis A; Dias DC; Yamoah K; Wu K
    Oncogene; 2004 Mar; 23(11):1985-97. PubMed ID: 15021886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cells.
    Xu GW; Toth JI; da Silva SR; Paiva SL; Lukkarila JL; Hurren R; Maclean N; Sukhai MA; Bhattacharjee RN; Goard CA; Medeiros B; Gunning PT; Dhe-Paganon S; Petroski MD; Schimmer AD
    PLoS One; 2014; 9(4):e93530. PubMed ID: 24691136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad and potent antiviral activity of the NAE inhibitor MLN4924.
    Le-Trilling VT; Megger DA; Katschinski B; Landsberg CD; Rückborn MU; Tao S; Krawczyk A; Bayer W; Drexler I; Tenbusch M; Sitek B; Trilling M
    Sci Rep; 2016 Feb; 6():19977. PubMed ID: 26829401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma.
    Tong S; Si Y; Yu H; Zhang L; Xie P; Jiang W
    Sci Rep; 2017 Jul; 7(1):5599. PubMed ID: 28717191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantifiable analysis of cellular pathway inhibition of a Nedd8-activating enzyme inhibitor, MLN4924, using AlphaScreen.
    Yan ZH; Burkhardt A; Loke HK; Chen J; Xu Q; Brauer P; Ma J; Lin Y; Garcia K; Dick LR; Bembenek ME
    Anal Biochem; 2013 Aug; 439(2):109-15. PubMed ID: 23624319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The NEDD8-activating enzyme inhibitor MLN4924 disrupts nucleotide metabolism and augments the efficacy of cytarabine.
    Nawrocki ST; Kelly KR; Smith PG; Keaton M; Carraway H; Sekeres MA; Maciejewski JP; Carew JS
    Clin Cancer Res; 2015 Jan; 21(2):439-47. PubMed ID: 25388161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy.
    Zhou LN; Xiong C; Cheng YJ; Song SS; Bao XB; Huan XJ; Wang TY; Zhang A; Miao ZH; He JX
    Neoplasia; 2022 Oct; 32():100823. PubMed ID: 35907292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of MRFAP1 turnover and interactions downstream of the NEDD8 pathway.
    Larance M; Kirkwood KJ; Xirodimas DP; Lundberg E; Uhlen M; Lamond AI
    Mol Cell Proteomics; 2012 Mar; 11(3):M111.014407. PubMed ID: 22038470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.